Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01308333
Other study ID # ED11
Secondary ID
Status Completed
Phase N/A
First received March 3, 2011
Last updated January 7, 2014
Start date April 2011
Est. completion date November 2011

Study information

Verified date January 2014
Source University Hospital Erlangen
Contact n/a
Is FDA regulated No
Health authority Germany: Ethics Commission
Study type Observational

Clinical Trial Summary

X-linked hypohidrotic ectodermal dysplasia (XLHED) is a complex genetic disorder characterized by lack of sweat, sebaceous, submucous, Meibomian and mammary glands, sparse hair and eyebrows, and oligodontia. Insufficient function of the respective glands may lead to chronic inflammatory processes in airways and eyes of the affected individuals. The investigators will quantify sweat glands of XLHED patients, assess chronic conjunctivitis and blepharitis in conjunction with quantitative and/or qualitative alterations of lacrimal fluid in these subjects, evaluate lung function and assess chronic inflammatory processes in the airways by NO measurements. The data should provide a basis for genotype-phenotype correlations.


Recruitment information / eligibility

Status Completed
Enrollment 38
Est. completion date November 2011
Est. primary completion date November 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 6 Years to 60 Years
Eligibility Inclusion Criteria:

- for patients: X-linked hypohidrotic ectodermal dysplasia caused by mutations in the gene EDA

- written informed consent

Exclusion Criteria:

- acute respiratory disease

- acute allergic problem, e.g. allergic coryza

- implantable electronic devices, e.g. pacemaker

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Germany University Hospital Erlangen, Competence Centre for Children with Ectodermal Dysplasias Erlangen Bavaria

Sponsors (2)

Lead Sponsor Collaborator
University Hospital Erlangen Edimer Pharmaceuticals

Country where clinical trial is conducted

Germany, 

References & Publications (1)

Dietz J, Kaercher T, Schneider AT, Zimmermann T, Huttner K, Johnson R, Schneider H. Early respiratory and ocular involvement in X-linked hypohidrotic ectodermal dysplasia. Eur J Pediatr. 2013 Aug;172(8):1023-31. doi: 10.1007/s00431-013-1985-8. Epub 2013 A — View Citation

See also
  Status Clinical Trial Phase
Completed NCT01564225 - A Phase 1, Open-label, Multicenter, Safety and Pharmacokinetic Study of EDI200 Phase 1
Active, not recruiting NCT01992289 - Extension Study of XLHED-Affected Male Subjects Treated With EDI200 in Protocol ECP-002 N/A
Completed NCT01629927 - Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia (ECP-012) N/A
Completed NCT01629940 - Phenotypic and Genetic Properties in Males at Risk for X-linked Hypohidrotic Ectodermal Dysplasia: Evaluation of an Early Diagnosis Technology and Tests to Assess Nutritional Status N/A
Completed NCT01398813 - X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) Carrier Outlook Toward Reproduction Survey N/A
Completed NCT02099552 - Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal Dysplasia N/A
Completed NCT01775462 - Phase 2 Study to Evaluate Safety, Pharmacokinetics, Immunogenicity and Pharmacodynamics/Efficacy of EDI200 in Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) Phase 2
Completed NCT01342133 - Sweat Duct Imaging in Mother/Newborn Dyads N/A
Completed NCT01398397 - Medical Record Review of Hypohidrotic Ectodermal Dysplasia Clinical Phenotype N/A
Completed NCT01135888 - Short Term Effects and Risks of Physical Exercise in Subjects With Hypohidrotic Ectodermal Dysplasia